Suppr超能文献

兔眼内压昼夜升高的肾上腺素能机制。

Adrenergic mechanism in circadian elevation of intraocular pressure in rabbits.

作者信息

Liu J H, Dacus A C, Bartels S P

机构信息

Eye Research Institute of Retina Foundation, Boston, MA 02114.

出版信息

Invest Ophthalmol Vis Sci. 1991 Jul;32(8):2178-83.

PMID:1676991
Abstract

Stimulation of the ocular sympathetic nerves is essential for the circadian elevation of intraocular pressure (IOP) in rabbits. Adrenergic mechanisms that participate in this elevation of IOP around the onset of darkness were investigated using selective adrenergic agents. Unilateral topical administration of 0.0001-0.1% prazosin, an alpha-1-adrenergic antagonist, at the onset of darkness caused a dose-dependent reduction of IOP elevation. After treatment with 0.1% prazosin, the concentration of norepinephrine (NE) in aqueous humor was not changed, but the aqueous humor protein concentration was reduced. The increase of aqueous flow, determined by fluorophotometry, after the onset of darkness was not affected by 0.1% prazosin treatment. Treatment of rauwolscine, an alpha-2-adrenergic antagonist, or timolol, a beta-adrenergic antagonist, was ineffective in reducing the circadian elevation of IOP. Apraclonidine, an alpha-2-adrenergic agonist, with concentrations of 0.0001-1% caused a dose-dependent reduction of IOP elevation. Treatment with 1% apraclonidine caused a 70% reduction of aqueous humor NE, a significant attenuation of the increase of aqueous flow, and no change of aqueous humor protein concentration. These results suggest that both an increase of aqueous outflow resistance (by alpha-1-adrenergic receptors) and an increase of aqueous flow (not exclusively by beta-adrenergic receptors) contribute to the circadian elevation of IOP. Prejunctional alpha-2-adrenergic receptors may serve as an autoregulating mechanism to limit the excess release of NE and hypertensive spike in IOP.

摘要

刺激兔眼交感神经对于眼内压(IOP)的昼夜升高至关重要。使用选择性肾上腺素能药物研究了参与黑暗开始时IOP升高的肾上腺素能机制。在黑暗开始时单侧局部应用0.0001 - 0.1%的哌唑嗪(一种α-1肾上腺素能拮抗剂)会导致IOP升高呈剂量依赖性降低。用0.1%哌唑嗪治疗后,房水中去甲肾上腺素(NE)的浓度未改变,但房水蛋白浓度降低。通过荧光光度法测定,黑暗开始后房水流量的增加不受0.1%哌唑嗪治疗的影响。用α-2肾上腺素能拮抗剂育亨宾或β-肾上腺素能拮抗剂噻吗洛尔治疗对降低IOP的昼夜升高无效。浓度为0.0001 - 1%的α-2肾上腺素能激动剂阿可乐定导致IOP升高呈剂量依赖性降低。用1%阿可乐定治疗导致房水NE减少70%,房水流量增加显著减弱,房水蛋白浓度无变化。这些结果表明,房水流出阻力增加(通过α-1肾上腺素能受体)和房水流量增加(并非仅通过β-肾上腺素能受体)都有助于IOP的昼夜升高。突触前α-2肾上腺素能受体可能作为一种自动调节机制来限制NE的过度释放和IOP的高血压峰值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验